tafasitamab in dlbcl
Published 4 years ago • 651 plays • Length 4:47Download video MP4
Download video MP3
Similar videos
-
2:02
the use of tafasitamab in dlbcl
-
1:31
long-term outcomes with tafasitamab plus lenalidomide for r/r dlbcl
-
1:17
the latest updates on tafasitamab in dlbcl
-
1:30
the role of tafasitamab in the lymphoma treatment landscape & promising results from clinical trials
-
1:36
the use of tafasitamab and lenalidomide in r/r dlbcl
-
1:32
dr. kahl on findings from the l-mind study with tafasitamab in dlbcl
-
1:33
dr. kahl on the utility of tafasitamab/lenalidomide in dlbcl
-
1:35
long-term follow-up of tafasitamab and lenalidomide in r/r dlbcl
-
1:14
tafasitamab plus lenalidomide approval generates excitement for second-line dlbcl
-
1:41
real-world efficacy of tafasitamab lenalidomide in r/r dlbcl & the importance of patient selection
-
2:50
tafasitamab-lenalidomide in r/r dlbcl: clinical trial results and real-world data
-
1:15
dr. abdulhaq on the safety profile of tafasitamab in dlbcl
-
1:05
updates on tafasitamab for the treatment of dlbcl
-
1:09
tafasitamab for r/r dlbcl
-
2:23
re-mind2: observational study comparing tafasitamab lenalidomide to available therapies in r/r dlbcl
-
1:22
dr. burke on the ongoing first-mind trial with tafasitamab in dlbcl
-
0:54
dr. burke on research with tafasitamab in lymphoma
-
2:15
frontmind: tafasitamab lenalidomide r-chop vs r-chop for newly diagnosed high-risk dlbcl
-
1:09
dr. flinn on opportunities for second-line tafasitamab in dlbcl